Explores the redefinition of the term biotechnology as applied to pharmaceuticals. This book examines the successful evolution of humanized monoclonal antibodies to treat rheumatoid arthritis and other diseases. It considers the disappointing results of genetic engineering and genomics that have isolated disease-responsible genes without effect.
Kõva köide · See väljaanne
€285,94Tarne 3-4 näd.
Pehme köide
€83,44Tarne 3-4 näd.
